HIV-1 phylodynamic analysis among people who inject drugs in Pakistan correlates with trends in illicit opioid trade.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2020
Historique:
received: 01 06 2019
accepted: 30 07 2020
entrez: 29 8 2020
pubmed: 29 8 2020
medline: 9 10 2020
Statut: epublish

Résumé

Pakistan is considered by the World Health Organization to currently have a "concentrated" HIV-1 epidemic due to a rapid rise in infections among people who inject drugs (PWID). Prevalence among the country's nearly 105,000 PWID is estimated to be 37.8% but has been shown to be higher in several large urban centers. A lack of public health resources, the common use of professional injectors and unsafe injection practices are believed to have fueled the outbreak. Here we evaluate the molecular characteristics of HIV-1 sequences (n = 290) from PWID in several Pakistani cities to examine transmission dynamics and the association between rates of HIV-1 transmission with regards to regional trends in opioid trafficking. Tip-to-tip (patristic) distance based phylogenetic cluster inferences and BEAST2 Bayesian phylodynamic analyses of time-stamped data were performed on HIV-1 pol sequences generated from dried blood spots collected from 1,453 PWID as part of a cross-sectional survey conducted in Pakistan during 2014/2015. Overall, subtype A1 strains were dominant (75.2%) followed by CRF02_AG (14.1%), recombinants/unassigned (7.2%), CRF35_AD (2.1%), G (1.0%) and C (0.3%). Nearly three quarters of the PWID HIV-1 sequences belonged to one of five distinct phylogenetic clusters. Just below half (44.4%) of individuals in the largest cluster (n = 118) did seek help injecting from professional injectors which was previously identified as a strong correlate of HIV-1 infection. Spikes in estimated HIV-1 effective population sizes coincided with increases in opium poppy cultivation in Afghanistan, Pakistan's western neighbor. Structured coalescent analysis was undertaken in order to investigate the spatial relationship of HIV-1 transmission among the various cities under study. In general terms, our analysis placed the city of Larkana at the center of the PWID HIV-1 epidemic in Pakistan which is consistent with previous epidemiological data.

Identifiants

pubmed: 32857765
doi: 10.1371/journal.pone.0237560
pii: PONE-D-19-15582
pmc: PMC7454939
doi:

Substances chimiques

Analgesics, Opioid 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0237560

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Syst Biol. 2016 Mar;65(2):250-64
pubmed: 26526428
Sex Transm Infect. 2013 Sep;89 Suppl 2:ii18-28
pubmed: 23314301
J Antimicrob Chemother. 2010 Aug;65(8):1562-6
pubmed: 20542904
AIDS. 2011 Jul 17;25(11):1427-30
pubmed: 21516026
Int J STD AIDS. 2004 Mar;15(3):209
pubmed: 15038874
PLoS Comput Biol. 2014 Apr 10;10(4):e1003537
pubmed: 24722319
AIDS. 2010 Jul;24 Suppl 2:S77-84
pubmed: 20610953
Mol Biol Evol. 2015 Jan;32(1):268-74
pubmed: 25371430
Mol Biol Evol. 2005 May;22(5):1185-92
pubmed: 15703244
Mol Biol Evol. 2016 Jul;33(7):1870-4
pubmed: 27004904
BMC Infect Dis. 2010 Jan 12;10:7
pubmed: 20064274
AIDS Res Hum Retroviruses. 1988 Apr;4(2):149-54
pubmed: 3365358
Virus Evol. 2018 Jun 08;4(1):vey016
pubmed: 29942656
Syst Biol. 2018 Sep 1;67(5):901-904
pubmed: 29718447
J Antimicrob Chemother. 2011 Dec;66(12):2823-6
pubmed: 21930572
Bioinformatics. 2014 Nov 15;30(22):3276-8
pubmed: 25095880
Asia Pac J Public Health. 2010 Jul;22(3 Suppl):159S-167S
pubmed: 20566549
Harm Reduct J. 2009 Jun 26;6:13
pubmed: 19558668
J Pak Med Assoc. 2010 Apr;60(4):300-7
pubmed: 20419976
BMC Bioinformatics. 2013 Nov 06;14:317
pubmed: 24191891
Virus Evol. 2015 May 26;1(1):vev003
pubmed: 27774277
J Acquir Immune Defic Syndr. 2009 May 1;51(1):85-90
pubmed: 19289969
Lancet HIV. 2018 Dec;5(12):e678-e679
pubmed: 30527323
Nucleic Acids Res. 2014 Oct;42(18):e144
pubmed: 25120265
Sex Transm Infect. 2013 Sep;89 Suppl 2:ii11-7
pubmed: 23843454
PLoS Comput Biol. 2009 Nov;5(11):e1000581
pubmed: 19956739
PLoS One. 2016 Dec 14;11(12):e0167839
pubmed: 27973597
PLoS One. 2011;6(7):e22449
pubmed: 21799857
J Clin Microbiol. 2012 Jun;50(6):1936-42
pubmed: 22403431
J Mol Evol. 2002 Feb;54(2):156-65
pubmed: 11821909
J Infect Dis. 2015 Mar 15;211(6):926-35
pubmed: 25312037
PLoS One. 2010 Mar 10;5(3):e9490
pubmed: 20224823
Bioinformatics. 2014 Aug 15;30(16):2272-9
pubmed: 24753484
J Mol Biol. 1990 Oct 5;215(3):403-10
pubmed: 2231712
Mol Biol Evol. 2013 May;30(5):1188-95
pubmed: 23418397
Infect Genet Evol. 2013 Oct;19:337-48
pubmed: 23660484

Auteurs

François Cholette (F)

National HIV and Retrovirology Laboratories, National Microbiology Laboratory at the JC Wilt Infectious Diseases Research Centre, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.
Department of Community Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada.

Jeffrey Joy (J)

British Columbia Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, Canada.
Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
Bioinformatics Programme, University of British Columbia, Vancouver, British Columbia, Canada.

Yann Pelcat (Y)

Public Health Risk Sciences Division, National Microbiology Laboratory, Public Health Agency of Canada, Saint-Hyacinthe, Québec, Canada.

Laura H Thompson (LH)

Department of Community Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada.

Richard Pilon (R)

National HIV and Retrovirology Laboratories, National Microbiology Laboratory at the JC Wilt Infectious Diseases Research Centre, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.

John Ho (J)

National HIV and Retrovirology Laboratories, National Microbiology Laboratory at the JC Wilt Infectious Diseases Research Centre, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.

Rupert Capina (R)

National HIV and Retrovirology Laboratories, National Microbiology Laboratory at the JC Wilt Infectious Diseases Research Centre, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.

Chris Archibald (C)

Centre for Communicable Diseases and Infection Control, Surveillance and Epidemiology Division, Public Health Agency of Canada, Ottawa, Ontario, Canada.

James F Blanchard (JF)

Centre for Global Public Health, University of Manitoba, Winnipeg, Canada.

Faran Emmanuel (F)

Centre for Global Public Health, University of Manitoba, Winnipeg, Canada.

Tahira Reza (T)

Centre for Global Public Health, Pakistan, Chak Shahzad, Islamabad, Pakistan.

Nosheen Dar (N)

Canada-Pakistan HIV/AIDS Surveillance Project, Islamabad, Pakistan.

Richard Harrigan (R)

Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.

John Kim (J)

National HIV and Retrovirology Laboratories, National Microbiology Laboratory at the JC Wilt Infectious Diseases Research Centre, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.

Paul Sandstrom (P)

National HIV and Retrovirology Laboratories, National Microbiology Laboratory at the JC Wilt Infectious Diseases Research Centre, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.
Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, Manitoba, Canada.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH